{
    "title": "GSK to spend up to $3.3 bln on Affinivax to boost vaccines roster",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10870251/Britains-GSK-buy-Affinivax-3-3-bln-vaccines-push.html",
    "date": "2022-05-31",
    "keywords": [
        "vaccine",
        "gsk",
        "aripaka",
        "nextgeneration",
        "business",
        "technology",
        "affinivax",
        "deal",
        "giant",
        "access",
        "companys",
        "roster",
        "pressure",
        "pipeline",
        "separation",
        "july",
        "consumer",
        "home",
        "toothpaste",
        "growth",
        "driver",
        "demand",
        "disruption",
        "product",
        "competition",
        "pfizer",
        "moderna",
        "mrna",
        "acquisition",
        "month",
        "appetite",
        "purchase",
        "oncology",
        "step",
        "direction",
        "regard",
        "strategy",
        "treatment",
        "money",
        "analyst",
        "laura",
        "hoy",
        "tuesday",
        "outlook",
        "development",
        "pneumonia",
        "meningitis",
        "bloodstream",
        "sinusitis",
        "older",
        "synflorix",
        "breadth",
        "immunity",
        "pathogen",
        "immuneboosting",
        "adjuvant",
        "pushkala",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila",
        "jane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}